Page results
-
Patients with an aggressive form of leukaemia will now be able to receive a breakthrough immunotherapy on the NHS which was developed and trialled at UCLH and UCL.
-
Nearly 200 people have visited a family-friendly open event in Islington which engaged the local community in the latest research and innovation in the NHS.
-
A new centre at UCLH launched today will work to ensure health research is accessible to everyone.
-
UCLH is to trial a COVID-19 vaccine developed by Imperial College London.
-
Patients with COVID-19 will be given the cystic fibrosis drug ‘Dornase alfa’ to determine if it can help improve survival by reducing excess inflammation in the lungs in a trial at UCLH.
-
Patient information for patients suffering from long COVID who are trying to return to physical activity,
-
A UCLH and UCL study has identified how a subset of immune cells are activated to kill cancerous cells, a finding in mice which could hold the key to new powerful therapies against cancer.
-
Today is the 72 anniversary of the NHS – and it is dedicated to our amazing staff.
-
The UCLH@Home service is helping patients like 80-year-old Margaret Stone to continue their recovery in their own home under the care of their hospital team.
-
Subscribe to updates from The Red Cell Network
